Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07322406 · ClinicalTrials.gov registry record · NA
Kaempferol Absorption and Pharmacokinetics Evaluation
A NA study of Healthy Volunteers and Longevity, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 3
- Study locations
NCT07322406: Recruiting NA study of Healthy Volunteers and Longevity, sponsored by University of Pittsburgh.
NCT07322406 is a NA study of Healthy Volunteers and Longevity that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 120 participants, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (75% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07322406, a NA study of Healthy Volunteers and Longevity, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study is a multi-site clinical trial designed to evaluate how the body absorbs and processes Kaempferol, a naturally occurring compound found in many plant-based foods. The primary purpose of the study is to measure the pharmacokinetics and biological absorption of Kaempferol in healthy adults. Participants will receive Kaempferol and undergo scheduled blood and urine collections over a short study period. These samples will be used to measure Kaempferol levels in the body and to assess safety and tolerability. In addition, selected biological samples will be analyzed to explore molecular changes associated with Kaempferol exposure using advanced laboratory methods. The study will be conducted at multiple research centers in the United States using a standardized protocol to ensure consistency across sites. The information collected will help improve understanding of how Kaempferol is absorbed and metabolized in humans and will support future research and regulatory evaluation.
Primary Outcome
The maximum observed plasma concentration of Kaempferol following oral administration, calculated from serial plasma samples collected at predefined time points.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Kaempferol
Study Locations (3)
New York
- Weill Cornell Medicine - New York
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-12-09 |
| Est. Completion | 2027-12-22 |
| Phase | NA |
What NCT07322406 shows while recruiting
NCT07322406 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (75% lower).
The record links to 5 conditions, with Healthy Volunteers appearing as the primary indexed condition, and to 1 intervention - of which Kaempferol is the first listed.
NCT07322406 reports a single indexed study location in New York, North Carolina, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07322406 about?
NCT07322406 is a clinical study titled "Kaempferol Absorption and Pharmacokinetics Evaluation". This study is a multi-site clinical trial designed to evaluate how the body absorbs and processes Kaempferol, a naturally occurring compound found in many plant-based foods. The primary purpose of the study is to measure the pharmacokinetics and biological absorption of Kaempferol in healthy adults....
What is the current status of trial NCT07322406?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-12-09. Estimated completion is 2027-12-22.
What conditions does trial NCT07322406 study?
This clinical trial studies the following conditions: Healthy Volunteers, Longevity, No Disease, Mitochondria Health, Pharmacokinetics and Biological Absorption of Kaempferol in Healthy Adult.
What interventions are being tested in trial NCT07322406?
The interventions under investigation include: Kaempferol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07322406?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07322406 being conducted?
This trial has 3 study locations across New York, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07322406's enrollment target sits among peer trials
120 71st of 283 higher than 211 of 283 other Healthy Volunteers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Volunteers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Acute Effects of High-intensity Interval Training With Mindfulness-based Recovery on Executive Function in Children
RECRUITING · NA
-
New Heart Imaging Techniques to Evaluate Possible Heart Disease
RECRUITING · NA
-
Blood Flow Restriction Training on Upper Extremity Grip Strength
RECRUITING · NA
-
Sociocultural & Biobehavioral Influences on Pain Expression and Assessment
RECRUITING · NA
-
Avocado and Postprandial Responses
RECRUITING · NA
-
Cybersickness Prevention and Mitigation in Virtual Reality for Healthy Volunteers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI